Will This Analyst Upgrade Help Envision Healthcare (EVHC) Stock Today?

NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Trump Rants on Earnings Season After Complaints From Buffett, Dimon

Trump Rants on Earnings Season After Complaints From Buffett, Dimon

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall

Here's Why Stock Picking Is Especially Important in the Retail Sector

Here's Why Stock Picking Is Especially Important in the Retail Sector

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Here's How to Trade Walmart, Nordstrom, Macy's and JCPenney After Earnings

Here's How to Trade Walmart, Nordstrom, Macy's and JCPenney After Earnings